Oh my! Detail on adverse events in the Novavax UK trial included in a conference presentation - wish the numbers were there: definitely less than Moderna. Will need to blow this up & try to work it out! ...1/n novavax.com/sites/default/… HT @londonboyjohn 
...A reminder of the vaccine efficacy rates for the phase 3 trial in the UK & the 2b efficacy trial in South Africa. It's an adjuvanted protein subunit vaccine...2/n
...They've made a booster aiming at the B.1.351 variant of concern. Here you see responses in baboons that had been immunized with the original a year ago. Bonus: you see with & without their adjuvant (same one used in the recently reported malaria vaccine) ...3/n
...The only other data on the booster. They're working on a variant-alone booster, & a bivalent version (an injection of the original vax plus variant-booster)...4/n
...Other news:
- 1st dose of Novavax in the UK COM-COV vax combo trial was on April 9.
- 1st dose in pediatric trial in the US was on April 26.
...5/5
- 1st dose of Novavax in the UK COM-COV vax combo trial was on April 9.
- 1st dose in pediatric trial in the US was on April 26.
...5/5
• • •
Missing some Tweet in this thread? You can try to
force a refresh
